We are live on ! Find out more
VERV

Verve Therapeutics
VERV

Delisted

VERV was delisted on the 24th of July, 2025.

Back to rankings

6 hedge funds and large institutions have $1.24M invested in Verve Therapeutics in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 169 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

81.59% less ownership

Funds ownership: 81.84% → 0.26% (-82%)

97% less funds holding

Funds holding: 175 → 6 (-169)

100% less capital invested

Capital invested by funds: $819M → $1.24M (-$818M)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 169

Holders
6
Holders Change
-169
Holders Change %
-96.57%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
169
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
XT
XTX Topco
Cayman Islands
+$955K
2
IA
IFP Advisors
Florida
+$4.29K

Top Sellers

Rank Fund Capital Flow
1
AI
Alphabet Inc
California
-$137M
2
BlackRock
BlackRock
New York
-$82.6M
3
PCM
Pentwater Capital Management
Florida
-$75.5M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$47.1M
5
CC
Casdin Capital
New York
-$46M
Name Holding Trade Value Shares
Change 		Change in
Stake
AB
151
Amalgamated Bank
New York
– -$28K -2,449 Closed
GFM
152
GF Fund Management
China
– -$24.3K -2,167 Closed
SCM
153
Sterling Capital Management
North Carolina
– -$21.4K -1,904 Closed
AUB
154
Atlantic Union Bankshares
Virginia
– -$13.5K -1,200 Closed
VWA
155
VSM Wealth Advisory
Maryland
– -$11.2K -1,000 Closed
VCM
156
Versant Capital Management
Arizona
– -$11K -980 Closed
US Bancorp
157
US Bancorp
Minnesota
– -$8.5K -757 Closed
CIAM
158
Caitong International Asset Management
Hong Kong
– -$8.42K -750 Closed
PNC Financial Services Group
159
PNC Financial Services Group
Pennsylvania
– -$8.15K -726 Closed
NS
160
NBC Securities
Alabama
– -$3K -350 Closed
Daiwa Securities Group
161
Daiwa Securities Group
Japan
– -$4K -321 Closed
RIL
162
Rothschild Investment LLC
Illinois
– -$3.2K -285 Closed
S
163
SignatureFD
Georgia
– -$2.2K -196 Closed
PS
164
Principal Securities
Iowa
– -$2.11K -188 Closed
Russell Investments Group
165
Russell Investments Group
United Kingdom
– -$1.86K -166 Closed
GI
166
GAMMA Investing
California
– -$1.85K -165 Closed
SS
167
SBI Securities
Japan
– -$1.77K -158 Closed
FFO
168
Fortitude Family Office
Arizona
– -$977 -87 Closed
GWM
169
Geneos Wealth Management
Colorado
– -$898 -80 Closed
Bessemer Group
170
Bessemer Group
New Jersey
– -$1K -48 Closed
PFBT
171
Parkside Financial Bank & Trust
Missouri
– -$506 -45 Closed
EWA
172
EverSource Wealth Advisors
Alabama
– -$34 -3 Closed
EP
173
Essential Partners
California
– -$11 -1 Closed
XT
174
XTX Topco
Cayman Islands
– +$955K +86,209 +222%
3 4 5 6
7

VERV Hedge Fund Activity: Q3 2025 in Review

6 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Verve Therapeutics (VERV) for Q3 2025, worth a combined $1.24M — down 100% from $819M a quarter earlier.

Sellers outnumbered buyers: 169 funds closed out of VERV and 0 opened new positions — a net loss of 169 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was XTX Topco, adding an estimated $955K. The largest seller was Alphabet Inc, exiting entirely with an estimated $137M sold.

  • 6 institutional investors held Verve Therapeutics (VERV) as of Q3 2025, down from 175 in Q2 2025.
  • Funds reported $1.24M of Verve Therapeutics stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Verve Therapeutics positions in Q3 2025 and 169 closed out, a net change of -169 holders.
  • The largest Verve Therapeutics buyer in Q3 2025 was XTX Topco, an estimated $955K added.
  • The largest Verve Therapeutics seller in Q3 2025 was Alphabet Inc, an estimated $137M sold.

Based on aggregated 13F filings for Q3 2025.